Özcan Met is heading the Cell Therapy Unit at the National Center for Cancer Immune Therapy, Denmark since 2010, directing all operational activities required for the manufacturing of cellular products intended for use in clinical trials.

He has more than 20 years of research experience in tailoring the immune system to combat cancer and is leading a team at the cutting edge in the development of novel cell-based technologies for patient treatment.